A094840 logo

Suprema HQ Inc. Stock Price

KOSDAQ:A094840 Community·₩57.6b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A094840 Share Price Performance

₩6,300.00
850.00 (15.60%)
₩6,300.00
850.00 (15.60%)
Price ₩6,300.00

A094840 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet.

1 Risk
2 Rewards

Suprema HQ Inc. Key Details

₩21.2b

Revenue

₩13.4b

Cost of Revenue

₩7.8b

Gross Profit

-₩9.9b

Other Expenses

₩17.7b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.93k
36.61%
83.36%
0.0004%
View Full Analysis

About A094840

Founded
2000
Employees
n/a
CEO
Jae-Won Lee
WebsiteView website
www.supremainc.com

Suprema HQ Inc. manufactures and sells of access control, time and attendance, and biometrics solutions worldwide. The company offers BioStar 2 access control, a security platform; BioStar 2 TA is a time and attendance module that serves as an add-on for the BioStar 2 platform; Suprema Mobile Access that allows user’s smartphone as a key to access doors, facilities, and other accesses; and Suprema CLUe, an open cloud integration platform. It provides biometric and RF/mobile readers and intelligent controllers; and peripherals, including thermal cameras, input and output modules, secure and door modules, as well as OEM fingerprint modules. In addition, the company offers NOVUS, an open platform, designed for use in any time and attendance or workforce management application. It serves the construction, data center, healthcare, commercial, infrastructure, and manufacturing industries. The company was formerly known as Suprema Inc. and changed its name to Suprema HQ Inc. in February 2016. The company was founded in 2000 and is headquartered in Seongnam-si, South Korea.

Recent A094840 News & Updates

Recent updates

No updates